Fundraising FoxAsterias Biotherapeutics
Menlo Park, US · Founded 2012 · Delaware corporation
Find your way into Asterias Biotherapeutics
Sign up to see every warm intro you have to Asterias Biotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Asterias Biotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JS
Jane S LebkowskiExecutive
MD
Michael D WestExecutive
KS
Katharine SpinkExecutive
JS
Judith SegallExecutive
PL
Pedro LichtingerExecutive
RW
Robert W PeabodyExecutive
Board
AA
Andrew ArnoBoard director
AK
Alfred KingsleyBoard director
RT
Richard T. LeBuhnBoard director
NR
Natale RicciardiBoard director
Reported raises · per SEC filings
Form D private placements$4.9M disclosed across 2 of 3 rounds · 2014–2015
▶$4MraisedFeb 2015 · BiotechnologyRule 506(b)
▶$4MraisedFeb 2015 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew ArnoDirector
- Jane S LebkowskiExecutive Officer
- Michael D WestExecutive Officer, Director
- Katharine SpinkExecutive Officer
- Judith SegallExecutive Officer, Director
- Pedro LichtingerExecutive Officer, Director
- Robert W PeabodyExecutive Officer, Director
- Alfred KingsleyDirector
- Natale RicciardiDirector
- Richard T. LeBuhnDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$11.7MofferedJun 2014 · 2 investors · BiotechnologyRule 506(b)
▶$11.7MofferedJun 2014 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- PEDRO LICHTINGERExecutive Officer
- ROBERT W PEABODYExecutive Officer, Director
- RICHARD T LeBUHNDirector
- JUDITH SEGALLDirector
- ALFRED D KINGSLEYDirector
- MICHAEL D WESTExecutive Officer, Director
- Offering amount
- $11.7M
- Minimum investment
- $1M
- Proceeds to insiders
- $1.7M
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$936KraisedJun 2014 · 1 investors · BiotechnologyRule 506(b)
▶$936KraisedJun 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ROBERT W PEABODYExecutive Officer, Director
- JUDITH SEGALLDirector
- PEDRO LICHTINGERExecutive Officer
- ALFRED D KINGSLEYDirector
- MICHAEL D WESTExecutive Officer, Director
- RICHARD T LeBUHNDirector
- Offering amount
- $3.3M
- Amount sold
- $936K
- Proceeds to insiders
- $468K
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Asterias Biotherapeutics raised?
- Asterias Biotherapeutics has disclosed $4.9M raised across 2 of its 3 known rounds.
- Where is Asterias Biotherapeutics headquartered?
- Asterias Biotherapeutics is headquartered in Menlo Park, US.